SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

The authors and journal apologize for errors in the above paper, which appeared in volume 26 part 3, pages 303–319. The errors relate to the legend of Fig. 1A on page 307 and the artwork of Fig. 8D on page 316:

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine-related cancer 2020-02, Vol.27 (2), p.X1-X2
Hauptverfasser: Han, Fei, Liu, Wen-bin, Li, Jian-jun, Zhang, Ming-qian, Yang, Jun-tang, Zhang, Xi, Hao, Xiang-lin, Yin, Li, Mao, Cheng-yi, Jiang, Xiao, Cao, Jia, Liu, Jin-yi
Format: Artikel
Sprache:eng
Schlagworte:
Erratum
Ovarian cancer
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The authors and journal apologize for errors in the above paper, which appeared in volume 26 part 3, pages 303–319. The errors relate to the legend of Fig. 1A on page 307 and the artwork of Fig. 8D on page 316:
ISSN:1351-0088
1479-6821
DOI:10.1530/ERC-18-0529e